A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., March 26, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture...
INVO has partnered with experienced reproductive specialists who are strong advocates of the INVOcell solutionClinic to be located in Birmingham, Alabama with a focus on providing INVOcell as an efficient, effective and affordable fertility treatment option for the...
SARASOTA, Fla., March 11, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
SARASOTA, Fla., March 8, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
SARASOTA, Fla., March 1, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
- Spain marks INVO's initial entry into the European market- Europe represents approximately 30% of the multi-billion dollar global fertility marketplace- The first three clinics in Spain have placed initial orders for INVOcell - an effective and affordable...
- Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan- Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million...
Key Developments and Future Initiatives Position INVOcell® Within the Severely Underserved Fertility MarketSARASOTA, Fla., Jan. 7, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO) ("Company") ('INVO"), a medical device company focused on commercializing the world's...
- Malaysia represents a significant addressable market opportunity with approximately 10% of the population suffering from infertility.- idsMED is one of the largest and most well-respected medical solutions providers in the region.- Product registration is already...
SARASOTA, Fla., Nov. 18, 2020 -- INVO Bioscience, Inc. (Nasdaq: INVO) developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced the formation of its Scientific Advisory Board (SAB) with the appointment of several prominent...